Predictive factors for the development of proteinuria in cancer patients treated with bevacizumab, ramucirumab, and aflibercept: a single-institution retrospective analysis

The development of proteinuria restricts the dose of anti-angiogenic agents, thereby reducing their efficacy. Thus, this retrospective study was undertaken to identify predictive factors of the development of angiogenesis inhibitor-induced proteinuria, and to elucidate if there is a difference in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanbayashi, Yuko, Ishikawa, Takeshi, Tabuchi, Yusuke, Sakaguchi, Koichi, Ouchi, Yoshimi, Otsuji, Eigo, Takayama, Koichi, Taguchi, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005043/
https://www.ncbi.nlm.nih.gov/pubmed/32029849
http://dx.doi.org/10.1038/s41598-020-58994-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005043/
https://www.ncbi.nlm.nih.gov/pubmed/32029849
http://dx.doi.org/10.1038/s41598-020-58994-5

Ejemplares similares